C. Liu

Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.

N. Kedersha, R. Chari, W. Blättler, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Enhancement of the selectivity and antitumor efficacy of a CC-1065 analogue through immunoconjugate formation.

S. Shah, R. Chari, V. Goldmacher, 1995, Cancer research.

The development of antibody delivery systems to target cancer with highly potent maytansinoids.

R. Chari, C. Liu, 1997, Expert opinion on investigational drugs.

Synergism between arsenic trioxide and cyclopamine in the inhibition of PC3 cell survival via the Hedgehog signaling pathway.

Y. Xu, Y. Xiong, Y. Guo, 2015, Neoplasma.

Assessing the role of E1A in the differential oncogenicity of group A and group C human adenoviruses.

G. Telling, J. Williams, M. Williams, 1995, Current topics in microbiology and immunology.

Disialoganglioside GD2 anti‐idiotypic monoclonal antibodies

N. Cheung, A. Cañete, N. Cheung, 1993, International journal of cancer.

Cure of multidrug-resistant human B-cell lymphoma xenografts by combinations of anti-B4-blocked ricin and chemotherapeutic drugs.

R. O'Connor, J. Lambert, C. Liu, 1996, Blood.